SCHEMBL9506103

SCHEMBL9506103

CC(C)C(N)C1CNC(=O)C1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
SYK P43405 18/20 0.35
FLT3 P36888 6/20 0.35
AURKB Q96GD4 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL524079 0.83
SCHEMBL10195889 0.83
SCHEMBL524081 0.83
SCHEMBL524080 0.83
SCHEMBL8312559 0.79 TSHR (0.41) TSHRSYKFLT3AURKB
SCHEMBL8312105 0.79 TSHR (0.41) TSHRSYKFLT3AURKB
SCHEMBL3114403 0.79 TSHR (0.41) TSHRSYKFLT3AURKB
SCHEMBL14749811 0.79
SCHEMBL6155366 0.79
SCHEMBL14671531 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2945950-B1 ISOMANNIDE DERIVATIVES AS INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE SANOFI SA (FR) 2017-03-01 EP disclosed
EP-0198271-B1 PEPTIDES MERCK PATENT GmbH (DE) 1993-06-09 EP disclosed
US-5215966-A For treatment of hypertension, hyperaldosteronism and cardiac insufficiency MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1993-06-01 US disclosed
US-4755592-A Statine-containing peptides useful in medicaments MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1988-07-05 US disclosed
EP-0272444-A2 Renin-inhibiting peptides MERCK PATENT GmbH (DE) 1988-06-29 EP disclosed
EP-0198271-A2 Peptides MERCK PATENT GmbH (DE) 1986-10-22 EP disclosed